BRAF and metastatic malignant neoplasm in the lymph nodes: Presently, our meta-analysis provided strong evidence that BRAF V600E/TERT promoter mutations were significantly correlated with lymph node metastasis, multifocality, distant metastasis, tumor recurrence, extrathyroidal extension, and dead of disease.